FindTrial
Sign In

Phase 3, open,clinical trial of NPC-02 for treatment of Wilson's disease.

Phase 3, open,clinical trial of NPC-02 for treatment of Wilson's disease.

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220112
Enrollment
Unknown
Registered
2005-09-13
Start date
2005-09-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wilson's disease

Interventions

investigational material(s) Generic name etc : NPC-02 INN of investigational material : Therapeutic category code : 392 Antidotes Dosage and Administration for Investigational material : Oral

Sponsors

Nobelpharma Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Wilson's disease(Adult,Infant, Pregnant woman)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026